Middle East respiratory syndrome coronavirus (MERS-CoV) - update
1 June 2013 - The Ministry of Health in Italy, through the European Union’s Early Warning Response System, has notified WHO of a laboratory-confirmed case with Middle East respiratory syndrome coronavirus (MERS-CoV) in a resident in the country.
The patient is a 45-year-old man with recent travel from Jordan. He returned to Italy on 25 May 2013 with symptoms of cough and fatigue. His condition deteriorated and he was hospitalised on 28 May 2013. He is currently in stable condition.
Laboratory test was conducted by the influenza reference laboratory of Tuscany and confirmed by the National Influenza Center of the Istituto Superiore di Sanità.
Globally, from September 2012 to date, WHO has been informed of a total of 51 laboratory-confirmed cases of infection with MERS-CoV, including 30 deaths.
WHO has received reports of laboratory-confirmed cases originating in the following countries in the Middle East to date: Jordan, Qatar, Saudi Arabia, and the United Arab Emirates (UAE). France, Germany, Italy, Tunisia and the United Kingdom also reported laboratory-confirmed cases; they were either transferred there for care of the disease or returned from the Middle East and subsequently became ill. In France, Tunisia and the United Kingdom, there has been limited local transmission among patients who had not been to the Middle East but had been in close contact with the laboratory-confirmed or probable cases.
Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns.
Health care providers are advised to maintain vigilance. Recent travellers returning from the Middle East who develop SARI should be tested for MERS-CoV as advised in the current surveillance recommendations. Specimens from patients’ lower respiratory tracts should be obtained for diagnosis where possible. Clinicians are reminded that MERS-CoV infection should be considered even with atypical signs and symptoms, such as diarrhoea, in patients who are immunocompromised.
Health care facilities are reminded of the importance of systematic implementation of infection prevention and control (IPC). Health care facilities that provide care for patients suspected or confirmed with MERS-CoV infection should take appropriate measures to decrease the risk of transmission of the virus to other patients, health care workers and visitors.
All Member States are reminded to promptly assess and notify WHO of any new case of infection with MERS-CoV, along with information about potential exposures that may have resulted in infection and a description of the clinical course. Investigation into the source of exposure should promptly be initiated to identify the mode of exposure, so that further transmission of the virus can be prevented.
WHO does not advise special screening at points of entry with regard to this event nor does it currently recommend the application of any travel or trade restrictions.
WHO continues to closely monitor the situation.
The following document has recently been published on the WHO website: